Eli Lilly and

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$19,292,000
$17,600,800
$15,557,700
$12,728,500
Gross Profit
16,408,300
14,592,500
13,109,900
10,504,300
EBITDA
8,388,000
7,882,000
7,503,900
4,162,600
EBIT
8,235,800
7,412,000
7,025,400
3,699,800
Net Income
6,636,000
5,582,500
5,660,500
2,759,300
Net Change In Cash
19,292,000
17,600,800
15,557,700
12,728,500
Free Cash Flow
677,900
8,612,000
1,283,000
-1,600,900
Cash
7,163,000
9,791,900
3,375,900
3,093,300
Basic Shares
898,002
898,800
899,793
900,604

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$65,179,000
$45,042,700
$34,124,100
$28,541,400
Gross Profit
54,615,000
36,624,400
27,041,900
21,911,600
EBITDA
27,936,500
15,227,600
8,567,800
8,660,500
EBIT
26,373,000
13,461,000
7,040,500
7,138,000
Net Income
20,638,300
10,590,000
5,240,400
6,244,800
Net Change In Cash
65,179,000
45,042,700
34,124,100
28,541,400
Cost of Revenue
-1,583,900
Free Cash Flow
8,972,000
414,300
-3,152,000
4,600,400
Cash
7,163,000
3,268,400
2,818,600
2,067,000
Basic Shares
898,002
904,059
903,284
950,182

Earnings Calls

QuarterEPS
2025-12-31
$7.54
2025-09-30
$7.02
2025-06-30
$6.31
2025-03-31
$3.34